To compare the presence of washout and the diagnostic performance of computed tomography (CT) and magnetic resonance imaging (MRI) for hepatocellular carcinoma (HCC) according to the presence of hepatic steatosis.

This retrospective study included 566 patients with chronic liver disease who had undergone hepatic resection for hepatic…[Read more]

promoter mutation and BRAF V600E mutation is of interest for therapeutic decision making. BMS-1 inhibitor The presence of a TERT promoter mutation is correlated to metastatic disease.

To report long-term outcomes on best-corrected visual acuity (BCVA) and treatment intervals with a treat-and-extend (T&E) regimen in patients with neovascular…[Read more]